GlassScriptPhysician profile
Kyle D Lindow
NPI 1780049494
$8,456.27
in general payments reported to CMS, 2019-2025
27 companies · $1,602 in 2025
The $1,602 reported for 2025 was more than what 79% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,684 · 2020: $1,730 · 2021: $1,303 · 2022: $187 · 2023: $1,178 · 2024: $772 · 2025: $1,602.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,703 · Travel and Lodging: $849.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,703.36 |
| Travel and Lodging | $848.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $2,314.11 | 2020-2025 | Puraply, Affinity, Via Matrix |
| Orthofix Medical, INC. | $1,340.48 | 2019 | |
| Treace Medical Concepts, INC. | $1,238.71 | 2020-2025 | |
| Paratek Pharmaceuticals, INC. | $634.37 | 2020-2025 | Nuzyra |
| Alon Medical Technology | $510.98 | 2019-2025 | |
| Arthrex, INC. | $482.45 | 2025 | |
| Stryker Corporation | $401.45 | 2019-2025 | N/A, Prostep Mica, Citrefix |
| Convatec INC. | $273.73 | 2023-2025 | |
| Pylant Medical | $188.47 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $152.14 | 2022-2023 | Seglentis |
| Abbott Laboratories | $145.26 | 2025 | Eterna |
| Horizon Therapeutics Plc | $130.26 | 2019-2022 | |
| Medline Industries LP | $122.89 | 2019-2020 | |
| Biocomposites INC | $76.61 | 2023 | Stimulan |
| Smith+Nephew, INC. | $63.40 | 2021-2025 | Renasys Touch, Stravix, Grafix Xc |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $54.64 | 2025 | |
| Globus Medical, INC. | $52.21 | 2025 | Senza |
| Nevro Corp. | $47.67 | 2022-2023 | Senza |
| Bioventus LLC | $44.44 | 2019-2020 | |
| Kci USA, INC. | $40.78 | 2021 | |
| Medtronic, INC. | $31.51 | 2024 | Intellis Adaptivestim |
| Kerecis Limited | $26.76 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Integra Lifesciences Corporation | $20.00 | 2020 | |
| Abbvie INC. | $18.91 | 2024 | |
| Grt US Holding, INC. | $17.45 | 2020 | |
| Lifenet Health | $14.92 | 2024 | Theragenesis Wound Matrix |
| Apria Healthcare LLC | $11.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Lindow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.